Tag: trends

Posts with tag: trends

Latest Posts

SailPoint Raises $1.38 Billion in Enlarged IPO, Pricing Shares at $23

SailPoint, an enterprise security software company, raised $1.38B in an expanded IPO, pricing shares at $23, its marketed range's top. The company now has a $12.8B market value.

Ardmore Shipping Reports Q4 Earnings

Ardmore Shipping Corp. reports Q4 earnings of $6.9 million, or 12 cents per share. Adjusted earnings were 25 cents per share, on revenue of $49.3 million.

Warren: Only Congress Can Close CFPB, Setting Up Showdown With Trump Over Agency

Sen. Elizabeth Warren says the law requires Congress to shutter the Consumer Financial Protection Bureau, setting up a potential legal clash with President Trump, after the administration moved to freeze the agency’s operations.

U.S. Stock Futures Rise on Reciprocal Tariff Talks, PPI Data

US stock futures inch higher as markets weigh tariff 'big one' and inflation data

Organon Q4 profit tops estimates

Organon & Co. (OGN) reported fourth-quarter net income of $109 million, beating Wall Street expectations. Earnings, adjusted for one-time gains and costs, were 90 cents per share. The pharmaceutical company posted revenue of $1.59 billion in the period.

Stock Futures Mixed as Investors Eye PPI Data, Ukraine Peace Talks Encourage Risk-Taking

U.S. stock futures steady ahead of PPI data, Russia-Ukraine peace talks boost risk appetite

Warren: Only Congress Can Shutter Consumer Bureau

Sen. Warren says only Congress can shutter the CFPB, setting up potential legal clash with Trump administration

Japan Automakers End Talks on Business Integration

Honda, Nissan and Mitsubishi Motors are ending talks to establish a business integration agreement.

MKS Instruments Q4 Earnings Beat Expectations

MKS Instruments Inc. (MKSI) reported fourth-quarter profit of $90 million. Earnings, adjusted for one-time gains and costs, came to $2.15 per share. Revenue was $935 million in the period.

NIH Funding Cuts Roil Biomedical Research, Raise Concerns

NIH funding cuts: Impact on drug research, layoffs, and the future of US science